Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank50
3Y CAGR-30.8%
5Y CAGR+1.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-30.8%/yr
Annual compound
5Y CAGR
+1.4%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$832000.00-54.1%
2024$1.81M+2.8%
2023$1.76M-29.7%
2022$2.51M-
2021$0.00-100.0%
2020$777000.00+67.8%
2019$463000.00-